The price of pomalidomide varies depending on the specification, region, and procurement channel. Please consult your local hospital or authorized pharmacy for specific costs. This is a prescription drug and must be used strictly according to your doctor's instructions. Do not purchase or adjust the dosage yourself.
Pomalidomide is indicated for patients with multiple myeloma. It must be used in combination with dexamethasone, and the dosage must be adjusted according to the patient's condition under the guidance of a physician. The following is important information regarding medication use:
Precautions
Contraindications
Contraindicated in pregnant women, as pomalidomide may cause fetal malformation or death.
Contraindicated in patients with known hypersensitivity to any component of the drug.
Special Populations
Women of childbearing potential must strictly practice contraception before, during, and after treatment and undergo regular pregnancy monitoring.
Male patients must use condoms during treatment and for 4 weeks after discontinuation.
Adverse Reaction Management
Common hematological toxicities (such as neutropenia and thrombocytopenia) require regular monitoring of blood counts. Dosage adjustment or discontinuation may be necessary if required.
Severe skin reactions (such as exfoliative dermatitis), hepatotoxicity, and the risk of thrombosis require immediate medical attention.
Dosage Adjustment: Patients with hepatic or renal insufficiency, or elderly patients, may require a reduced starting dose.
When used in combination with a potent CYP1A2 inhibitor (such as fluvoxamine), the pomalidomide dose needs to be reduced.
Medical Guidance:
Pomalidomide should be used under the guidance of a hematologist or oncologist. Regular follow-up visits are necessary during treatment to monitor efficacy and adverse reactions. If symptoms such as fever, difficulty breathing, or severe rash occur, seek immediate medical attention.
Note: Informed consent must be obtained before using this medication, and participation in a pregnancy prevention plan is required to ensure compliance with risk management requirements.
